FON-2020-1222_INFO.pdf (3.05 MB)

Infographic. Immune-related adverse events with PD-1 versus PD-L1 inhibitors: a meta-analysis of 8730 patients from clinical trials

figure

posted on 2021-05-20, 09:31 authored by Guru P. Sonpavde, Petros Grivas, Daniel Hennessy, Yushun Lin, Jay D Hunt

Infographic summary of the article ‘ Immune-related adverse events with PD-1 versus PD-L1 inhibitors: a meta-analysis of 8730 patients from clinical trials’

Funding

EMD Serono, Inc, MA, USA; an affiliate of Merck KGaA, Darmstadt, Germany

History

Usage metrics

Read the peer-reviewed publication

Future Oncology

Keywords

anti-PD-1 anti-PD-L1 immune-related adverse events immune checkpoint inhibitor meta-analysis Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

Licence

CC BY-NC-ND 4.0